Important note: Information in this article was accurate in 2005. The state of the art may have changed since the publication date.
Important note: Information in this article was accurate in 2005. The state of the art may have changed since the publication date.
Reuters NewMedia - November 17, 2005
The trend suggests a wave of infections from a drug resistant strain of the virus may be on the way, they said in a study published in the British Medical Journal.
The report by the UK Group on Transmitted HIV Drug Resistance warned that the reduction in effective drugs to treat patients represented "a major clinical and public health problem."
Their research was based on 2,357 HIV positive patients between 1996 and 2003.
They found that 335 patients showed some degree of resistance to one or more of the antiretroviral drugs used to fight the HIV virus, which can lead to AIDS.
Most, 257 of them, were resistant to drugs in one class only, 44 were resistant to drugs within two classes and 34 were resistant to drugs in the three most commonly used drug classes.
The study said this was equivalent to a 14 percent rate of resistance over the whole time period, rising to 19 percent for the most recent year of the study, 2002-3.
This is higher than in other industrialized countries.
Drug resistance is estimated at 7 percent among chronically infected HIV patients in the United States, with a 6 percent resistance in France and 10 percent elsewhere in Europe.
051117
RE051121
Copyright © 2005 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Contact Reuters.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .